APA (7th ed.) Citation

Hyerim Ha, Jin Hyoung Kang, Do Yeun Kim, Seung Jin Bae, & Hee Yeon Lee. (2022). The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS. BMC.

Chicago Style (17th ed.) Citation

Hyerim Ha, Jin Hyoung Kang, Do Yeun Kim, Seung Jin Bae, and Hee Yeon Lee. The Value Measurement of Emerging Therapeutics in Renal Cell Carcinoma: ASCO Value Framework and ESMO-MCBS. BMC, 2022.

MLA (9th ed.) Citation

Hyerim Ha, et al. The Value Measurement of Emerging Therapeutics in Renal Cell Carcinoma: ASCO Value Framework and ESMO-MCBS. BMC, 2022.